Unusual Case of Idiopathic Membranous Later Developing Non-Hodgkin’s Lymphoma

Rubina Naqvi^*

Department of Nephrology, Sindh Institute of Urology and Transplantation (SIUT), Karachi, Pakistan.

DOI: 10.4236/ojneph.2014.43016                

Abstract

A 30-year-old male presented to nephrology services as a case of nephrotic syndrome and membranous nephropathy was found on renal biopsy. He was treated for this pathology with steroid and cytotoxic drugs and remained in remission for 3 years and then presented with non Hodgkin’s lymphoma.

Keywords

Nephrotic Syndrome, Idiopathic Membranous Nephropathy, Non-Hodgkin’s Lymphoma

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	Pontecelli, C. (2007) Membranous Nephropathy. Journal of Nephrology, 20, 268-287.
[2]	Cattarn, D.C. (2002) Membranous Nephropathy: Quo Vadis? Kidney International, 61, 349-350. http://dx.doi.org/10.1046/j.1523-1755.2002.00125.x
[3]	Fervenza, F.C., Sethi, S. and Specks, U. (2008) Idiopathic Memranous Nephropathy: Diagnosis and Treatment. Clinical Journal of the American Society of Nephrology, 3, 905-919. http://dx.doi.org/10.2215/CJN.04321007
[4]	Jones, D.B. (1957) Nephrotic Glomerulonephritis. American Journal of Pathology, 33, 313-329.
[5]	Perna, A., Schieppati, A., Zamora, J., Giuliano, G.A., Braun, N. and Remuzzi, G. (2004) Immunnosuppressive Therapy for Idiopathic Memranous Nephropathy: A Systemic Review. American Journal of Kidney Diseases, 44, 385-401. http://dx.doi.org/10.1053/j.ajkd.2004.05.020
[6]	Jha, V., Gangoli, A., Saha, T.K., Sud, K., Gupta, K.L., Joshi, K. and Sakhuja, V. (2007) A Randomized, Controlled Trial of Steroid and Cyclophosphamide in Adults with Nephrotic Syndrome Caused by Idiopathic Memranous Nephropathy. Journal of the American Society of Nephrology, 18, 1899-1904. http://dx.doi.org/10.1681/ASN.2007020166
[7]	Gupta, K., Nada, R., Das, A. and Kumar, M.S. (2008) Membranoproliferative Glomerulonephritis in a Carcinoma with Unknown Primary: An Autopsy Study. Indian Journal of Pathology and Microbiology, 51, 230-233. http://dx.doi.org/10.4103/0377-4929.41665
[8]	Richendollar, B.G., His, E.D. and Cook, J.R. (2009) Extramedullary Plasmacytoma like Posttransplantation Lymphoproliferative Disorders: Clinical and Pathological Features. American Journal of Clinical Pathology, 132, 581-588. http://dx.doi.org/10.1309/AJCPX70TIHETNBRL
[9]	Hasserjian, R.P., Chen, S., Perkin, S.L., del Leval, L., Kinney, M.C., Barry, T.S., Said, J., Lim, M.S., Finn, W.G., Medeiros, L.J., Harris, N.L. and O’Malley, D.P. (2009) Immunomodulator Agent Related Lymphoproliferative Disorders. Modern Pathology, 22, 1532-1540.
[10]	Da’as, N., Polliak, A., Cohen, Y., Amir, G., Darmon, D., Kleinman, Y., Goldfarb, A.W. and Ben-Yahuda, D. (2001) Kidney Involvement and Renal Manifestation in Non-Hodgkin’s Lymphoma and Lymphocytic Leukemia: A Retrospective Study in 700 Patients. European Journal of Haematology, 67, 158-164. http://dx.doi.org/10.1034/j.1600-0609.2001.5790493.x
[11]	Suzuki, Y., Niitsu, N., Hayama, M., Katayama, T., Ishii, R., Osaka, M., Miyazaki, K., Danbara, M., Horie, R., Yoshida, T., Nakamura, N. and Higashihara, M. (2009) Lymphoproliferative Disorders after Immunosuppressive Therapy for Aplastic Anemia: A Case Report and Literature Review. Acta Haematologica, 121, 21-26. http://dx.doi.org/10.1159/000209225